- Home
- ATHA vs SPCB Comparison
ATHA vs SPCB Comparison
Compare ATHA & SPCB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATHA
- SPCB
- Stock Information
- Founded
- ATHA 2011
- SPCB 1988
- Country
- ATHA United States
- SPCB Israel
- Employees
- ATHA N/A
- SPCB N/A
- Industry
- ATHA Medicinal Chemicals and Botanical Products
- SPCB Semiconductors
- Sector
- ATHA Health Care
- SPCB Technology
- Exchange
- ATHA Nasdaq
- SPCB Nasdaq
- Market Cap
- ATHA 21.0M
- SPCB 19.2M
- IPO Year
- ATHA 2020
- SPCB N/A
- Fundamental
- Price
- ATHA $0.53
- SPCB $13.42
- Analyst Decision
- ATHA Buy
- SPCB
- Analyst Count
- ATHA 4
- SPCB 0
- Target Price
- ATHA $11.25
- SPCB N/A
- AVG Volume (30 Days)
- ATHA 235.4K
- SPCB 3.0M
- Earning Date
- ATHA 02-20-2025
- SPCB 11-14-2024
- Dividend Yield
- ATHA N/A
- SPCB N/A
- EPS Growth
- ATHA N/A
- SPCB N/A
- EPS
- ATHA N/A
- SPCB 1.02
- Revenue
- ATHA N/A
- SPCB $26,843,000.00
- Revenue This Year
- ATHA N/A
- SPCB $6.72
- Revenue Next Year
- ATHA N/A
- SPCB $15.83
- P/E Ratio
- ATHA N/A
- SPCB $13.15
- Revenue Growth
- ATHA N/A
- SPCB 5.23
- 52 Week Low
- ATHA $0.41
- SPCB $2.55
- 52 Week High
- ATHA $4.30
- SPCB $13.49
- Technical
- Relative Strength Index (RSI)
- ATHA 41.88
- SPCB 78.09
- Support Level
- ATHA $0.52
- SPCB $7.84
- Resistance Level
- ATHA $0.57
- SPCB $10.05
- Average True Range (ATR)
- ATHA 0.04
- SPCB 2.29
- MACD
- ATHA -0.00
- SPCB 0.54
- Stochastic Oscillator
- ATHA 11.82
- SPCB 99.29
About ATHA Athira Pharma Inc.
Athira Pharma Inc is a late clinical-stage biopharmaceutical company focused on developing small molecules engineered to restore neuronal health and slow neurodegeneration. Its pipeline candidates are; Fosgonimeton (ATH-1017) a subcutaneously administered, small molecule positive modulator of the HGF/MET system for CNS disorders, ATH-1020 is a novel small molecule compound designed to be an orally available once-daily treatment, to enhance the HGF/MET system. ATH-1105 is a novel small molecule compound designed to be an orally available once-daily treatment, to enhance the HGF/MET system, and several other compounds in preclinical discovery and development for neurodegenerative diseases, including ATH-1018 and ATH-1019.
About SPCB SuperCom Ltd. (Israel)
SuperCom Ltd is an Israel-based provider of traditional and digital identity solutions, providing safety, identification, tracking, and security products to governments and organizations. The company comprises three main Strategic Business Units: e-Gov; IoT and Connectivity, which is the key revenue driver; and Cyber Security. Besides, it also offers a wide range of solutions that include national ID registries, e-passports, biometric visas, automated fingerprint identification systems, digitized driver's licenses, and electronic voter registration and election management using the common platform. The geographical segments of the company include Africa, European countries, South America, the United States, Israel, and the Asia Pacific.